Novel transcript, antisense to TUBB4A (ENSG00000268191)

ENSG00000268191 is a novel, non-coding RNA transcript located antisense to the TUBB4A gene. It does not encode a protein, and currently there is no evidence suggesting a direct functional or disease-associated role for this transcript. The TUBB4A gene itself encodes β-tubulin 4A, a structural protein critical for microtubule function, predominantly in the brain, and mutations in TUBB4A cause neurological disorders such as hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) and dystonia. However, no therapeutic agents, biomarker applications, or safety issues have been established for the antisense transcript[1][2][3]. This molecule is not considered a canonical therapeutic target (such as a receptor, transporter, enzyme, etc.), as it is an uncharacterized non-coding RNA transcript. There is no evidence of it being a drug target, biomarker, or being involved in therapeutic modulation. There are no recognized aliases, interactions, or classifications outside of being a non-coding or antisense RNA. Marked as is_incorrect: true since it does not fit the criteria of a therapeutic target, and "novel transcript, antisense to TUBB4A" does not correspond to a receptor, enzyme, or any well-known druggable target class[1].